Concepedia

Brady Sillman

BS

Statistics

Publications

10

Citations

826

H-Index

10

Active since

2017

Affiliations

University of Nebraska Medical Center(Current)

Nebraska Medical Center

Temple University

Brady Sillman is an author at University of Nebraska Medical Center specializing in drug delivery, pharmacology, and nanomedicine.

ORCID

Publications per year

2017–2023

10

Publications

10

Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice

Prasanta K. Dash, Rafal Kaminski, Ramona Bella et al. · Nature Communications · 2019 · 296 citations · Full text

, , +16

Creation of a long-acting nanoformulated dolutegravir

Brady Sillman, Aditya N. Bade, Prasanta K. Dash et al. · Nature Communications · 2018 · 129 citations · Full text

, , +17

A year-long extended release nanoformulated cabotegravir prodrug

Tanmay A. Kulkarni, Aditya N. Bade, Brady Sillman et al. · Nature Materials · 2020 · 110 citations · Full text

, , +12

CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice

Prasanta K. Dash, Chen Chen, Rafal Kaminski et al. · Proceedings of the National Academy of Sciences · 2023 · 76 citations · Full text

, , +17

Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugs

Divya Prakash Gnanadhas, Prasanta K. Dash, Brady Sillman et al. · Journal of Clinical Investigation · 2017 · 51 citations · Full text

, , +17

1–5 of 10